Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD)

Growth Hormone and IGF Research

Volumn 18, Issue 4, 2008, Pages 307-317

  Chihara, K ^a   Kato, Y ^b   Kohno, H ^c   Takano, K ^d   Tanaka, T ^e   Teramoto, A ^f   Shimatsu, A ^g  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b SHIMANE UNIVERSITY   (Japan)

^c FUKUOKA CHILDREN S HOSPITAL   (Japan)

^d TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^e Tanaka Growth Clinic   (Japan)

^f NIPPON MEDICAL SCHOOL   (Japan)

^g NATIONAL HOSPITAL ORGANIZATION KYOTO MEDICAL CENTER   (Japan)

Author keywords

Body composition; Japanese adults; Long term growth hormone treatment; Safety; Serum lipids

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; CORTICOSTEROID; GROWTH HORMONE; HUMAN GROWTH HORMONE; LIPID; SEX HORMONE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; THYROXINE;

ADULT; AGE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANXIETY; ARTHRALGIA; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; AUTOMUTILATION; BACKACHE; BEDTIME DOSAGE; BODY COMPOSITION; BODY FAT; CLINICAL TRIAL; COLON DIVERTICULOSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVULSION; CRANIOPHARYNGIOMA; DEPERSONALIZATION; DEPRESSION; DIARRHEA; DISEASE SEVERITY; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG FATALITY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; EDEMA; FEMALE; FLU LIKE SYNDROME; GASTROENTERITIS; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE DEFICIENCY; HEMATURIA; HORMONE SUBSTITUTION; HUMAN; INSOMNIA; JAPANESE; LEAN BODY WEIGHT; LEUKOCYTE COUNT; LIPID BLOOD LEVEL; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MENTAL INSTABILITY; MULTICENTER STUDY; MUSCLE HYPERTONIA; MUSCLE WEAKNESS; MYALGIA; OPEN STUDY; OUTCOME ASSESSMENT; PAIN; PHARYNGITIS; PRIORITY JOURNAL; QUALITY OF LIFE; SECOND CANCER; SEX DIFFERENCE; SIDE EFFECT; SPINAL CORD TUMOR; SYMPTOM; THINKING; TREATMENT DURATION; UPPER RESPIRATORY TRACT INFECTION; WEIGHT GAIN;

ADOLESCENT; ADULT; AGED; ALGORITHMS; DOUBLE-BLIND METHOD; FEMALE; GROWTH DISORDERS; HORMONE REPLACEMENT THERAPY; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; JAPAN; MALE; MIDDLE AGED; PLACEBOS; TIME FACTORS; TREATMENT OUTCOME;

EID: 44349179721     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2007.12.001     Document Type: Article

References (35)

1. Maison P., Griffith S., Nicoue-Beglah M., Haddad N., Balkau B., and Chanson P. Impact of growth hormone (GH) treatment on cardiovascular risk factors in GH-deficient adults: a metaanalysis of blinded, randomized, placebo-controlled trials. J. Clin. Endocrinol. Metab. 89 (2004) 2192-2199
2. Attanasio A.F., Lamberts S.W.J., Matranga A.M.C., et al. Adult growth hormone (GH)-deficient patients demonstrate heterogeneity between childhood onset and adult onset before and during human GH treatment. J. Clin. Endocrinol. Metab. 82 (1997) 82-88
3. Gibney J., Wallace J.D., Spinks T., et al. The effects of 10 years of recombinant human growth hormone (GH) in adult GH-deficient patients. J. Clin. Endocrinol. Metab. 84 (1999) 2596-2602
4. Growth Hormone Research Society. Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: summary statement of the growth hormone research society workshop on adult growth hormone deficiency. J. Clin. Endocrinol. Metab. 83 (1998) 379-381
5. Drake W.M., Howell S.J., Monson J.P., and Shalet S.M. Optimizing GH therapy in adults and children. Endocr. Rev. 22 (2001) 425-450
6. Tanaka T., Takano K., Hanew K., et al. Registration system for growth hormone (GH) treatment with standardized immunoreactive GH values in Japan. Endocr. J. 45 (1998) 459-465
7. Murakami Y., Yokohama T., Oiso Y., and Kato Y. Clinical features of adult hypopituitary patients in a national survey. In: Kato Y. (Ed). Annual Report of the Japan Study Group on Hypothalamo-Pituitary Disorders (2002), Ministry of Health, Labour and Welfare, Tokyo 170-176 (in Japanese)
8. Chihara K., Kato Y., Kohno H., Takano K., Tanaka T., Teramoto A., and Shimatsu A. Efficacy and safety of growth hormone (GH) in the treatment of adult Japanese patients with GH deficiency: a randomised, placebo-controlled study. Growth Horm. IGF Res. 16 (2006) 132-142
9. Carroll P.V., Christ E.R., and Members of Growth Hormone Research Society Scientific Committee. Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. J. Clin. Endocrinol. Metab. 83 (1998) 382-395
10. Chihara K., Koledova E., Shimatsu A., et al. Adult GH deficiency in Japanese patients: effects of GH treatment in a randomised, placebo-controlled trial. Eur. J. Endocrinol. 151 (2004) 343-350
11. Chihara K., Koledova E., Shimatsu A., et al. An individualized GH dose regimen for long-term GH treatment in Japanese patients with adult GH deficiency. Eur. J. Endocrinol. 153 (2005) 57-65
12. Irie M., Kato Y., Takano K., et al. Phase III study of recombinant human growth hormone for growth hormone deficiency in adults. Jpn. Pharmacol. Ther. 25 (1997) 223-235
13. Irie M., Shizume K., Takano K., Kato Y., Tanaka T., Chihara K., et al. Growth hormone replacement therapy in adults with growth hormone deficiency: a double-blind, placebo-controlled crossover trial in Japan. Endocrinol. Metab. 2 Suppl B (1995) 17-23
14. Murray R.D. Adult growth hormone replacement: current understanding. Curr. Opin. Pharmacol. 3 (2003) 642-649
15. Span J.P.T., Pieters G.F.F.M., Sweep C.G.J., Hermus A.R.M.M., and Smals A.G.H. Gender difference in insulin-like growth factor I response to growth hormone (GH) treatment in GH-deficient adults: role of sex hormone replacement. J. Clin. Endocrinol. Metab. 85 (2000) 1121-1125
16. Ezzat S., Fear S., Gaillard R.-C., Gayle C., Landy H., Marcovitz S., Mattioni T., Nussey S., Rees A., and Svanberg E. Gender-specific responses of lean body composition and non-gender-specific cardiac function improvement after GH replacement in GH-deficient adults. J. Clin. Endocrinol. Metab. 87 (2002) 2725-2733
17. Drake W.M., Coyte D., Camacho-Hubner C., Jivanji N.M., Kaltsas G., Wood D.F., Trainer P.J., Grossman A.B., Besser G.M., and Monson J.P. Optimizing growth hormone replacement therapy by dose titration in hypopituitary adults. J. Clin. Endocrinol. Metab. 83 (1998) 3913-3919
18. Hoffman A.R., Strasburger C.J., Zagar A., Blum W.F., Kehely A., and Hartman M.L. Efficacy and tolerability of an individualized dosing regimen for adult growth hormone replacement therapy in comparison with fixed body weight-based dosing. J. Clin. Endocrinol. Metab. 89 (2004) 3224-3233
19. Götherström G., Svensson J., Koranyi J., et al. A prospective study of 5 years of GH replacement therapy in GH-deficient adults: sustained effects on body composition, bone mass, and metabolic indices. J. Clin. Endocrinol. Metab. 86 (2001) 4657-4665
20. Kuromaru R., Kohno H., Ueyama N., Hassan H.M.S., Honda S., and Hara T. Long-term prospective study of body composition and lipid profiles during and after growth hormone (GH) treatment in children with GH deficiency: gender-specific metabolic effects. J. Clin. Endocrinol. Metab. 83 (1998) 3890-3896
21. Molitch M.E., Clemmons D.R., Malozowski S., Merriam G.R., Shalet S.M., Vance M.L., and Stephens P.A. Evaluation and treatment of adult growth hormone deficiency: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 91 (2006) 1621-1634
22. Kehely A., Bates P.C., Frewer P., Birkett M., Blum W.F., Mamessier P., Ezzat S., Ho K.K., Lombardi G., Luger A., Marek J., Russell-Jones D., Sonksen P., and Attanasio A.F. Short-term safety and efficacy of human GH replacement therapy in 595 adults with GH deficiency: a comparison of two dosage algorithms. J. Clin. Endocrinol. Metab. 87 (2002) 1974-1979
23. Koranyi J., Svensson J., Götherström G., Sunnerhagen K.S., Bengtsson B.-A., and Johannsson G. Baseline characteristics and the effects of five years of GH replacement therapy in adults with GH deficiency of childhood or adulthood onset: a comparative prospective study. J. Clin. Endocrinol. Metab. 86 (2001) 4693-4699
24. Yu H., Spitz M.R., Mistry J., et al. Plasma levels of insulin-like growth factor-I and lung cancer risk: a case-control analysis. J. Natl. Cancer. Inst. 91 (1999) 151-156
25. Renehan A.G., Zwahlen M., Minder C., et al. Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 363 (2004) 1346-1353
26. Svensson J., and Bengtsson B.-A. Safety of growth hormone replacement therapy in adults. In: Abs R., and Feldt-Rasmussen U. (Eds). Growth hormone deficiency in adults. 10 years of KIMS (2004), Oxford PharmaGenesis™ Ltd, Oxford 315-322
27. Abs R., Bengtsson B.-A., Hernberg-Ståhl E., et al. GH replacement in 1034 growth hormone deficient hypopituitary adults: demographic and clinical characteristics, dosing and safety. Clin. Endocrinol. 50 (1999) 703-713
28. Swerdlow A.J., Reddingius R.E., Higgins C.D., et al. Growth hormone treatment of children with brain tumours and risk of tumour recurrence. J. Clin. Endocrinol. Metab. 85 (2000) 4444-4449
29. Frajese G., Drake W.M., Loureiro R.A., et al. Hypothalamo-pituitary surveillance imaging in hypopituitary patients receiving long-term GH replacement therapy. J. Clin. Endocrinol. Metab. 86 (2001) 5172-5175
30. Hatrick A.G., Boghalo P., Bingham J.B., Ayres A.B., Sonksen P.H., and Russell-Jones D.L. Does GH replacement therapy in adult GH-deficient patients result in recurrence or increase in size of pituitary tumours?. Eur. J. Endocrinol. 146 (2002) 807-811
31. Chung T.T., Drake W.M., Evanson J., et al. Tumour surveillance imaging in patients with extrapituitary tumours receiving growth hormone replacement. Clin. Endocrinol. 63 (2005) 274-279
32. Karavitaki N., Warner J.T., and Marland A. GH replacement does not increase the risk of recurrence in patients with craniopharyngioma. Clin. Endocrinol. 64 (2006) 556-560
33. Doga M., Bonadonna S., and Gola M. Current guidelines for adult GH replacement. Rev. Endocr. Metab. Disord. 6 (2005) 63-70
34. Holmes S.J., and Shalet S.M. Which adults develop side-effects of growth hormone replacement?. Clin. Endocrinol. 43 (1995) 143-149
35. Yamamoto H., Sohmiya M., Oka N., and Katio Y. Effects of aging and sex on plasma insulin-like growth factor-1 (IGF-1) levels in normal adults. Acta Endocrinol. 124 (1991) 497-500